Biofrontera Achieved Two Milestones Associated With Series B-3 Convertible Preferred Stock Warrants; Exercise Of Warrants Will Trigger $8M Payments To Company
Biofrontera实现了与B-3系列可转换优先股认股权证相关的两个里程碑;认股权证的行使将触发向公司支付800万美元的款项
Biofrontera Achieved Two Milestones Associated With Series B-3 Convertible Preferred Stock Warrants; Exercise Of Warrants Will Trigger $8M Payments To Company
Biofrontera实现了与B-3系列可转换优先股认股权证相关的两个里程碑;认股权证的行使将触发向公司支付800万美元的款项
使用浏览器的分享功能,分享给你的好友吧